In Re: Zofran (Ondansetron) Products Liability Lit v., No. 21-1517 (1st Cir. 2023)
Annotate this CaseThis opinion or order relates to an opinion or order originally issued on January 9, 2023.
Download PDF
United States Court of Appeals For the First Circuit No. 21-1517 IN RE: ZOFRAN (ONDANSETRON) PRODUCTS LIABILITY LITIGATION HEATHER PERHAM, et al., Plaintiffs, Appellants, v. GLAXOSMITHKLINE LLC, Defendant, Appellee, SUN PHARMACEUTICAL INDUSTRIES LTD.; SANDOZ, INC.; PROVIDENCE HEALTH SYSTEM; NOVARTIS PHARMACEUTICALS CORP.; MCKESSON CORPORATION; DOES 1 through 100, inclusive, TEVA PHARMACEUTICAL USA; GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC., Defendants. ERRATA SHEET The opinion of this Court issued on January 9, 2022, is amended as follows: On page 3, line 24, "U.S.C.A." is replaced with "U.S.C."
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
